Hepatitis B virus-related mortality in rheumatoid arthritis patients undergoing long-term low-dose glucocorticoid treatment: A population-based study
Open Access
- 1 July 2018
- journal article
- research article
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 117 (7) , 566-571
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Hepatitis B virus reactivation associated with anti‐neoplastic therapyJournal of Gastroenterology and Hepatology, 2012
- A fatal case of hepatitis B virus (HBV) reactivation during long-term, very-low-dose steroid treatment in an inactive HBV carrierClinical and Molecular Hepatology, 2012
- Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapyAnnals of the Rheumatic Diseases, 2011
- The kaleidoscope of glucorticoid effects on immune systemAutoimmunity Reviews, 2011
- State-of-the-art: rheumatoid arthritisAnnals of the Rheumatic Diseases, 2010
- Corticoterapia: minimizando efeitos colateraisJornal de Pediatria, 2007
- Very low‐dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: A multicenter, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 2005
- Low‐dose prednisolone in addition to the initial disease‐modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: A two‐year randomized trialArthritis & Rheumatism, 2005
- Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective studyJournal of Medical Virology, 2003
- Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-upNew England Journal of Medicine, 1995